The COL1A2 gene plays a critical role in the development and functioning of connective tissues in the body. Mutations in this gene are associated with Osteogenesis Imperfecta (OI), a group of genetic disorders characterized by brittle bones that break easily, often with little or no apparent cause. The COL1A2 gene encodes the pro-alpha2 chain of type I collagen, a major structural component of bones.
To diagnose and assess the risk of Osteogenesis Imperfecta, a genetic test targeting the COL1A2 gene can be performed. This test involves analyzing the DNA to identify mutations in the COL1A2 gene that are known to cause OI. Identifying a mutation can help in confirming a diagnosis of OI, understanding the severity of the condition, and guiding treatment options. It can also provide valuable information for family planning and genetic counseling for affected families.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the COL1A2 Gene Osteogenesis Imperfecta Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted with high precision and accuracy, ensuring reliable results for patients and their families. This facility is equipped with state-of-the-art technology and staffed by experts in genetic testing, providing a crucial resource for individuals and families affected by Osteogenesis Imperfecta.
The SERPINH1 gene plays a crucial role in the proper formation of collagen, a key component of bone structure. Mutations in the SERPINH1 gene are linked to Osteogenesis Imperfecta Type 10 (OI Type 10), a rare genetic disorder characterized by brittle bones that are prone to fracture, among other symptoms. To diagnose this specific form of Osteogenesis Imperfecta, genetic testing of the SERPINH1 gene can be conducted.
DNA Labs UAE offers a specialized genetic test for the SERPINH1 gene to identify mutations associated with Osteogenesis Imperfecta Type 10. This test is essential for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding treatment options. The test is priced at 4400 AED and involves analyzing the patient's DNA to detect mutations in the SERPINH1 gene that are known to cause the disorder. This precise genetic testing can provide valuable information for affected individuals and their families, contributing to better management and care plans tailored to the patient's specific condition.
The FKBP10 gene plays a crucial role in the development and maintenance of the body's connective tissues, including bones. Mutations in the FKBP10 gene can lead to Osteogenesis Imperfecta Type 11 (OI Type 11), a rare but severe form of brittle bone disease. This condition is characterized by fragile bones that break easily, often with little or no apparent cause, along with other possible symptoms such as joint laxity, muscle weakness, and hearing loss.
To diagnose this specific type of Osteogenesis Imperfecta, a genetic test is available that screens for mutations in the FKBP10 gene. This test is crucial for confirming the diagnosis of OI Type 11, understanding the risk of passing the condition to future generations, and guiding treatment decisions.
In the UAE, this specialized genetic test is offered by DNA Labs UAE, a leading provider of genetic testing services. The cost of the FKBP10 Gene Osteogenesis Imperfecta Type 11 Genetic Test is 4400 AED. This comprehensive test is conducted with a high level of accuracy and confidentiality, ensuring that individuals and families affected by or at risk of OI Type 11 receive the vital information they need for managing the condition.
The SP7 Gene Osteogenesis Imperfecta Type 12 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SP7 gene, which are associated with Osteogenesis Imperfecta Type 12 (OI Type 12). Osteogenesis Imperfecta, also known as brittle bone disease, is a group of genetic disorders that primarily affect the bones, leading to their increased fragility and susceptibility to fractures. Type 12 is a rare form of this condition, characterized by specific genetic anomalies in the SP7 gene that impact bone formation and health.
This test is crucial for individuals suspected of having OI Type 12, as it provides definitive genetic evidence of the condition, enabling accurate diagnosis and the possibility of tailored treatment plans. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect mutations in the SP7 gene.
At DNA Labs UAE, the cost of the SP7 Gene Osteogenesis Imperfecta Type 12 Genetic Test is set at 4400 AED. The price reflects the comprehensive nature of the test, including the sophisticated techniques used to identify the genetic markers associated with the condition. Given the complexity of Osteogenesis Imperfecta and the significant impact it has on individuals and families, this test represents a critical step towards managing the disease through personalized medicine approaches.
The BMP1 gene plays a critical role in bone development and repair, and mutations in this gene are associated with Osteogenesis Imperfecta (OI) Type 13, a rare form of brittle bone disease. The BMP1 Gene Osteogenesis Imperfecta Type 13 Genetic Test is a specialized diagnostic tool used to detect specific mutations in the BMP1 gene that are linked to this condition. This test is vital for early diagnosis, allowing for appropriate management and treatment plans to be established for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the BMP1 gene to identify the presence of disease-causing mutations. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately diagnose this rare genetic disorder. Early detection through this test can significantly improve the quality of life for individuals with Osteogenesis Imperfecta Type 13 by enabling targeted interventions and support.
The TMEM38B Gene Osteogenesis Imperfecta Type 14 Genetic Test is a specialized diagnostic tool designed to identify mutations in the TMEM38B gene, which are linked to Osteogenesis Imperfecta (OI) Type 14. Osteogenesis Imperfecta, also known as brittle bone disease, is a group of genetic disorders that mainly affect the bones, leading to their increased fragility and susceptibility to fractures. Type 14 of this condition is a rare form attributed to specific genetic anomalies in the TMEM38B gene.
This genetic test involves analyzing the patient's DNA to search for mutations in the TMEM38B gene that are known to cause the disease. Identifying these mutations can confirm a diagnosis of OI Type 14, allowing for appropriate management and treatment plans to be developed. It can also provide essential information for family planning and genetic counseling for affected families.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE employs state-of-the-art technology and methodologies to ensure accurate and reliable results. The cost of the TMEM38B Gene Osteogenesis Imperfecta Type 14 Genetic Test is 4400 AED, reflecting the specialized nature of the test and the expertise required to interpret its results.
By opting for this test, patients and their families can gain valuable insights into their genetic health, enabling informed decisions about their medical care and future.
The WNT1 gene plays a critical role in bone formation and development, and mutations in this gene can lead to Osteogenesis Imperfecta (OI) Type 15, a rare and severe form of the disorder characterized by bone fragility, skeletal abnormalities, and, in some cases, problems with the nervous system. To diagnose this condition accurately, genetic testing for mutations in the WNT1 gene is crucial.
At DNA Labs UAE, a specialized test is available for individuals suspected of having Osteogenesis Imperfecta Type 15. This test involves analyzing the WNT1 gene for specific mutations that are known to cause the condition. The procedure is designed to be thorough and is carried out in a state-of-the-art laboratory by professionals experienced in genetic diagnostics.
The cost of the WNT1 gene Osteogenesis Imperfecta Type 15 genetic test at DNA Labs UAE is 4400 AED. While the price might seem high, it's important to consider the complexity of the testing process and the significant impact that a precise diagnosis can have on treatment planning and management of the condition. Early and accurate diagnosis can greatly assist in adopting the best care and interventions to manage symptoms and improve the quality of life for individuals with Osteogenesis Imperfecta Type 15.
The IFITM5 gene plays a crucial role in bone development and mineralization, and mutations in this gene are associated with Osteogenesis Imperfecta (OI) Type 5. Osteogenesis Imperfecta, also known as brittle bone disease, is a group of genetic disorders characterized by fragile bones that break easily. Type 5 is distinguished from other types by certain unique clinical features, including hyperplastic callus formation, calcification of the interosseous membrane of the forearm, and an abnormality of the toes.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the IFITM5 gene, providing a definitive diagnosis of Osteogenesis Imperfecta Type 5. This test is crucial for affected individuals and their families for several reasons. Firstly, it allows for a precise diagnosis, distinguishing OI Type 5 from other types of OI and other bone disorders. Secondly, it provides valuable information for genetic counseling, helping families understand the risk of OI Type 5 in future pregnancies. Lastly, the test results can inform treatment decisions and management plans to improve the quality of life for those affected.
The cost of the IFITM5 gene Osteogenesis Imperfecta Type 5 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the specific mutations in the IFITM5 gene associated with the condition. Given the complexity and the specialized nature of this genetic testing, the price reflects the advanced technology and expertise involved in providing accurate and reliable results.
Individuals considering this test are encouraged to discuss it with their healthcare provider to understand its benefits and implications fully.
The SERPINF1 gene plays a critical role in bone formation and mineralization, and mutations in this gene are associated with Osteogenesis Imperfecta Type 6 (OI Type 6), a rare form of the disorder characterized by increased bone fragility, low bone mass, and susceptibility to fractures. OI Type 6 is distinguished from other types of Osteogenesis Imperfecta by its specific radiological findings and the absence of blue sclera.
The genetic test for OI Type 6 involves analyzing the SERPINF1 gene to identify mutations that cause the condition. This test is crucial for confirming the diagnosis, understanding the disease's genetic basis, and guiding treatment and management decisions. It can also provide valuable information for family planning and genetic counseling for affected families.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the SERPINF1 gene test for Osteogenesis Imperfecta Type 6 is 4400 AED. Conducted in a state-of-the-art facility, the test is performed by experienced geneticists and laboratory technicians who ensure accurate and reliable results. DNA Labs UAE provides comprehensive support throughout the testing process, including pre-test counseling, sample collection guidance, and post-test interpretation and counseling to help individuals and families understand the results and their implications.
The CRTAP Gene Osteogenesis Imperfecta Type 7 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the CRTAP gene, which are associated with Osteogenesis Imperfecta (OI) Type 7. Osteogenesis Imperfecta, also known as brittle bone disease, is a group of genetic disorders that mainly affect the bones, leading to frequent fractures, reduced bone density, and, in some cases, other health issues. Type 7 is a rare form of OI and involves mutations in the CRTAP gene, which plays a crucial role in collagen formation and bone strength.
This genetic test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any abnormalities in the CRTAP gene. The results of this test can provide essential information for the diagnosis, management, and treatment planning of Osteogenesis Imperfecta Type 7. It can also be valuable for family planning and genetic counseling for families affected by this condition.
The cost of the CRTAP Gene Osteogenesis Imperfecta Type 7 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the CRTAP gene and provide reliable results. Individuals considering this test should consult with their healthcare provider to discuss its benefits and implications fully.
